1. Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd‐line therapy for relapsed and refractory multiple myeloma – a phase II trial. (16th December 2016) Authors: Mey, Ulrich J. M.; Brugger, Wolfram; Schwarb, Heike; Pederiva, Stefanie; Schwarzer, Andreas; Dechow, Tobias; Jehner, Paul; Rauh, Jacqueline; Taverna, Christian J.; Schmid, Mathias; Schmidt‐Hieber, Martin; Doerfel, Steffen; Fischer, Natalie; Ruefer, Axel; Ziske, Carsten; Knauf, Wolfgang; Cathomas,... Journal: British journal of haematology Issue: Volume 176:Number 5(2017) Page Start: 770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improved survival of older patients with multiple myeloma in the era of novel agents. Issue 4 (21st April 2015) Authors: Mey, Ulrich J. M.; Leitner, Christoph; Driessen, Christoph; Cathomas, Richard; Klingbiel, Dirk; Hitz, Felicitas Journal: Hematological oncology Issue: Volume 34:Issue 4(2016:Dec.) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Outcome of older myeloma patients in relationship to comorbidities and availability of second‐generation novel agents in a real‐life setting. Issue 4 (22nd May 2022) Authors: Lalive d'Epinay, Murielle; Güsewell, Sabine; Graf, Nicole; Mey, Ulrich J. M.; Driessen, Christoph; Hitz, Felicitas Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Salvage Chemotherapy with R-DHAP in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma. (13th September 2016) Authors: Schirmbeck, Nadine G. D.; Mey, Ulrich J. M.; Olivieri, Attilio; Ko, Yon-Dschun; Kaiser, Ulrich; Flieger, Dimitri; Witzens-Harig, Mathias; Schmidt-Wolf, Ingo G. H. Journal: Cancer investigation Issue: Volume 34:Number 8(2016) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗